Many studies have focused on SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) co-
infection consequences. However, after a vaccination plan against COVID-19, the cases of …

Objectives To characterize the plasma immune profile of patients with tuberculosis (TB)-
COVID-19 compared with COVID-19, TB, or healthy controls and to evaluate in vitro the …

Objectives The interaction of COVID-19 and tuberculosis (TB) are still poor characterized.
Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and …

Background and aim Patients with COVID-19 and tuberculosis coinfection are at an
increased risk of severe disease and death. We therefore sought to evaluate the current …

Background The impact of previous SARS-CoV-2 infection on the systemic immune
response during tuberculosis (TB) disease has not been explored. Methods An …

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …

SARS-CoV-2 and latent Mycobacterium tuberculosis infection are both highly co-prevalent
in many parts of the globe. Whether exposure to SARS-CoV-2 influences the antigen …

Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2
infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an …

Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are currently the two main
causes of death among infectious diseases. There is an increasing number of studies trying …

Background Data on the coincidence of Tuberculosis (TB) and Coronavirus disease 2019
(COVID-19) are limited. We sought to investigate the clinical characteristics and outcomes of …